Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy (CERTAIN)

This study has been completed.
Information provided by (Responsible Party):
Radiant Research Identifier:
First received: November 9, 2010
Last updated: January 5, 2012
Last verified: January 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)